WET MACULAR DEGENERATION

Clinical trials for WET MACULAR DEGENERATION explained in plain language.

Never miss a new study

Get alerted when new WET MACULAR DEGENERATION trials appear

Sign up with your email to follow new studies for WET MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New Vision-Saving drug challenges standard treatment for blinding eye disease

Disease control Not yet recruiting

This study is testing whether a new eye injection called tiespectus works as well as the current standard treatment (aflibercept) for wet age-related macular degeneration, a leading cause of vision loss in older adults. Researchers will enroll 960 people who haven't received trea…

Matched conditions: WET MACULAR DEGENERATION

Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

WET MACULAR DEGENERATION

Get alerted when new WET MACULAR DEGENERATION trials appear

New Vision-Saving drug challenges standard treatment for blinding eye disease